A new liquid biopsy approach developed by Johns Hopkins Kimmel Cancer Center investigators could revolutionize brain cancer detection by identifying circulating DNA fragments from tumors and immune cells in blood samples, potentially enabling earlier diagnosis.
Ismael Seáñez’s lab develops brain wave decoder that may help in spinal cord injury rehabilitation
A computer scientist from Washington University in St. Louis developed a problem-solving architecture modeled on neurobiology that leverages quantum mechanical behavior to guarantee optimal solutions to complex problems.
Researchers in JMU’s College of Health and Behavioral Studies have developed a cutting-edge method to diagnose balance disorders and treat diseases common in middle-aged and elderly Americans.
A brisk walk, a splash of water aerobics, or even a light jog around the block – if your heart rate goes up then so too will your brain health according to ...
BACKGROUNDMesenchymal stem cell-derived extracellular vesicles (MSC-EVs) can traverse the blood-brain barrier due to their small size. This characteristic makes them a research hotspot for the treatment of Parkinson’s disease (PD) and is
A new study found that a gene recently recognized as a biomarker for Alzheimer’s disease is actually a cause of it, due to its previously unknown secondary function that triggers a pathway that disrupts how cells in the brain turn genes on and off.
Getting enough exercise can be especially helpful—and especially challenging—for people with Parkinson’s disease. In a new study, patients who received a weekly email newsletter with Parkinson’s-specific exercise tips saw a significant improvement in exercise capacity after 12 weeks.
Erythritol, a commonly used sugar substitute often marketed as “healthy,” may impair blood vessel health by disrupting the brain’s ability to produce a critical compound, according to new research. Scientists will present their findings at the 2025 American Physiology Summit in Baltimore. The Summit is the flagship annual meeting of the American Physiological Society (APS).
Women who experience traumatic brain injuries face distinct challenges and barriers to recovery because of anatomic, hormonal, socioeconomic, and cultural differences as compared to men.
A gift from DMT Quest to UC San Diego will support research on the effects of the psychedelic DMT on the human brain, with potential to help treat depression, addiction and neurological conditions such as stroke.
Mayo Clinic researchers have identified a potential new way to monitor the progression of high-grade gliomas, one of the most aggressive types of brain cancer. Their feasibility study suggests that a personalized blood test tailored to each patient's tumor DNA could provide a faster and less invasive way to determine if the cancer is advancing.
PatientIQ, a leading health care technology company specializing in patient outcomes data, has expanded its support for national clinical registries with the launch of electronic health record (EHR)-integrated data submission for the American Spine Registry (ASR)—a collaborative effort between the American Association of Neurological Surgeons (AANS) and the American Association of Orthopaedic Surgeons (AAOS).
In a landmark clinical trial, coordinated by the Alzheimer's Disease Cooperative Study at UC San Diego, people at risk for Alzheimer's who exercised at low or moderate-high intensity showed less cognitive decline when compared to those receiving usual care.
Temple University, Philadelphia - Brain tissue analysis of an animal model reveals the potential role of immune system dysfunction in the onset and progression of Alzheimer’s Disease (AD).
EXPLORER total body PET scanner is creating a new way to visualize the protective barrier to the brain to reveal impacts from cancer and other diseases.
روتشستر، مينيسوتا — كشفت دراسة جديدة من مايو كلينك أن الأشخاص المصابين بمتلازمة توريت يملكون عددًا أقل بنسبة تصل إلى 50٪ من نوع محدد من خلايا الدماغ التي تساعد في تهدئة الإشارات الحركية المفرطة، مقارنةً بالأشخاص غير المصابين. وقد يكون هذا النقص سببًا رئيسيًا في عدم كبح الإشارات الحركية، مما يؤدي إلى التشنجات اللاإرادية التي تُعد السمة المميزة لهذا الاضطراب.
Un nuevo estudio de Mayo Clinic descubrió que las personas con síndrome de Tourette poseen aproximadamente la mitad de un tipo específico de célula cerebral responsable de calmar los signos de movimiento hiperactivo, en comparación con las personas sin la condición. Este déficit puede ser una razón crucial por la cual las señales motoras no se controlan adecuadamente, lo que lleva a los tics involuntarios que caracterizan el trastorno.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right